As of April 16, 2025, Cytokinetics (CYTK) has a market cap of $4.60 billion USD. According to our data, Cytokinetics is ranked No.2679 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $4.60 B |
-17.21%
|
Dec 31, 2024 | $5.55 B |
-43.66%
|
Dec 29, 2023 | $9.85 B |
82.21%
|
Dec 30, 2022 | $5.41 B |
0.53%
|
Dec 31, 2021 | $5.38 B |
119.35%
|
Dec 31, 2020 | $2.45 B |
95.85%
|
Dec 31, 2019 | $1.25 B |
67.88%
|
Dec 31, 2018 | $0.75 B |
-22.45%
|
Dec 29, 2017 | $0.96 B |
-32.92%
|
Dec 30, 2016 | $1.43 B |
16.16%
|
Dec 31, 2015 | $1.23 B |
30.59%
|
Dec 31, 2014 | $0.95 B |
23.23%
|
Dec 31, 2013 | $0.77 B |
64.14%
|
Dec 31, 2012 | $0.47 B |
-31.25%
|
Dec 30, 2011 | $0.68 B |
-54.07%
|
Dec 31, 2010 | $1.48 B |
-28.18%
|
Dec 31, 2009 | $2.06 B |
2.11%
|
Dec 31, 2008 | $2.02 B |
-39.75%
|
Dec 31, 2007 | $3.35 B |
-36.76%
|
Dec 29, 2006 | $5.30 B |
14.72%
|
Dec 30, 2005 | $4.62 B |
-36.39%
|
Dec 31, 2004 | $7.26 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
![]() USA
|
Market Cap | = | CYTK Stock Price | * | CYTK Shares Outstanding |
= | $38.56 | * | 0.12 B | |
= | $4.60 B |